4.6 Review

Hypovitaminosis D and peripheral arterial disease: Emerging link beyond cardiovascular risk factors

Journal

EUROPEAN JOURNAL OF INTERNAL MEDICINE
Volume 23, Issue 8, Pages 674-681

Publisher

ELSEVIER
DOI: 10.1016/j.ejim.2012.07.001

Keywords

Atherosclerosis; Cardiovascular disease; Peripheral arterial disease; Vitamin D

Funding

  1. Novo Nordisk
  2. Novartis
  3. Miro
  4. Sanofi-Aventis
  5. Pfizer
  6. Wyeth
  7. Bayer

Ask authors/readers for more resources

Vitamin D has received increasing interest for its beneficial effect on health. Beyond its conventional role in bone metabolism, emerging evidence suggests a possible link between low vitamin D levels and cardiovascular disease (CVD), including peripheral arterial disease (PAD), and cardiovascular risk factors. Vitamin D interacts either directly with the vascular tree or indirectly through its association with cardiovascular risk factors, but the exact mechanism remains controversial. This review outlines the association between hypovitaminosis D and PAD. Both entities are quite prevalent in the general population and, therefore, their potential association might have important clinical implications. Whether vitamin D deficiency represents a novel risk factor for PAD/CVD, and whether vitamin D supplementation would reduce the burden of CVD still remains to be answered. Until then, vitamin D intake is not recommended for PAD/CVD prevention. Outdoor physical activity, coupled with adequate but safe sun exposure, is a healthy lifestyle practice suggested for the prevention of both PAD and hypovitaminosis D. (C) 2012 European Federation of Internal Medicine. Published by Elsevier B. V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available